Atlas Trials

An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels

Clinical trial NCT02052986 · UNKNOWN

Trial details

NCT number
NCT02052986
Sponsor
New York Hospital Queens
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Dyslipidemia
Primary completion
2015-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.